<DOC>
	<DOCNO>NCT02916719</DOCNO>
	<brief_summary>Magnetic resonance imaging ( MRI ) method choice breast cancer perform loco-regional stag direct treatment . European Guidelines ( EUSOMA ) currently recommend MRI initial evaluation assessement neoadjuvant chemotherapy ( NAC ) response , breast cancer . The standard care consist realize MRI start NAC another one 's end , six month later . There currently consensus realization interval MRI early assessment chemosensitivity tumor . It would allow though alteration therapeutic regimen event non response . Similarly , consensus interval MRI perform . Some recent study suggest Diffusion-weighted Magnetic Resonance Imaging interesting evaluation early response . However , preliminary study quantitative measure realize region interest ( ROI ) method . A response neoadjuvant chemotherapy result elevate value apparent diffusion coefficient ( ADC ) . There is'nt publish data potential interest breast MRI radiotherapy treatment surgical treatment . Therefore , expect benefit study : - monitor early modification perfusion diffusion parameter level tumor radiotherapy , correlate histology surgical monster . - ass MRI able objectivate early sign response radiotherapy neo-adjuvant treatment breast cancer . This record link NCT02858934 record share cohort patient</brief_summary>
	<brief_title>Monitoring Breast Cancers Treated Neoadjuvant Radiotherapy Via Magnetic Resonance Imaging</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Age â‰¥ 18 year Histological diagnosis unifocal invasive breast carcinoma , special type ( ductal carcinoma ) Tumor Staging : cT12N0M0 Luminal A B Candidate breast conserving surgery N0status confirm lymph node cytology Multifocal/multicentric disease Prior thoracic radiotherapy Pregnancy SBR3 grade Triple negative status benefit neoadjuvant chemotherapy</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>neo-adjuvant radiotherapy</keyword>
	<keyword>breast cancer</keyword>
	<keyword>MRI</keyword>
</DOC>